Total Payments
$1,176
2024 Payments
$366.99
Companies
6
Transactions
16
Medicare Patients
2,608
Medicare Billing
$626,758
Payment Breakdown by Category
Food & Beverage$1,163 (98.9%)
Education$12.70 (1.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,163 | 15 | 98.9% |
| Education | $12.70 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Insmed, Inc. | $877.63 | 10 | $0 (2024) |
| Medtronic, Inc. | $108.12 | 1 | $0 (2022) |
| Actelion Pharmaceuticals US, Inc. | $98.29 | 1 | $0 (2023) |
| Boston Scientific Corporation | $40.76 | 1 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $31.61 | 2 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $19.35 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $366.99 | 3 | Insmed, Inc. ($366.99) |
| 2023 | $500.57 | 7 | Insmed, Inc. ($402.28) |
| 2022 | $276.59 | 4 | Insmed, Inc. ($108.36) |
| 2021 | $18.91 | 1 | Merck Sharp & Dohme Corporation ($18.91) |
| 2019 | $12.70 | 1 | Merck Sharp & Dohme Corporation ($12.70) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $149.81 | General |
| Category: Respiratory | ||||||
| 04/24/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $139.78 | General |
| Category: Respiratory | ||||||
| 03/14/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $77.40 | General |
| Category: Respiratory | ||||||
| 12/07/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $120.44 | General |
| Category: Respiratory | ||||||
| 11/17/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $7.52 | General |
| Category: Respiratory | ||||||
| 10/11/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $98.29 | General |
| Category: Cardiology | ||||||
| 09/22/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $149.65 | General |
| Category: Respiratory | ||||||
| 05/22/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $5.28 | General |
| Category: Respiratory | ||||||
| 04/13/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $2.68 | General |
| Category: Respiratory | ||||||
| 01/17/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $116.71 | General |
| Category: Respiratory | ||||||
| 12/08/2022 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $108.36 | General |
| Category: Respiratory | ||||||
| 10/07/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Respiratory | ||||||
| 06/08/2022 | Boston Scientific Corporation | General - Thrombectomy (Device) | Food and Beverage | In-kind items and services | $40.76 | General |
| Category: General - Thrombectomy_PI | ||||||
| 04/23/2022 | Medtronic, Inc. | ENDURANT IIS (Device) | Food and Beverage | In-kind items and services | $108.12 | General |
| Category: Aortic Stent Grafts | ||||||
| 02/11/2021 | Merck Sharp & Dohme Corporation | DIFICID (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/15/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Education | In-kind items and services | $12.70 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 396 | 879 | $199,469 | $100,321 |
| 2022 | 14 | 553 | 1,004 | $230,202 | $112,943 |
| 2021 | 18 | 752 | 1,417 | $383,976 | $180,878 |
| 2020 | 12 | 907 | 1,817 | $494,818 | $232,616 |
Total Patients
2,608
Total Services
5,117
Medicare Billing
$626,758
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 103 | 289 | $108,664 | $47,569 | 43.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 93 | 224 | $33,600 | $20,631 | 61.4% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 22 | 60 | $11,400 | $7,008 | 61.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 61 | $9,150 | $5,784 | 63.2% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 21 | 61 | $7,930 | $5,084 | 64.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 42 | 75 | $9,750 | $4,576 | 46.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 33 | $9,405 | $4,367 | 46.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 65 | $7,150 | $4,181 | 58.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $2,420 | $1,120 | 46.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 127 | 367 | $137,992 | $64,923 | 47.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 114 | 214 | $32,100 | $17,720 | 55.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 93 | $13,950 | $8,799 | 63.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 75 | $8,250 | $4,579 | 55.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 42 | 74 | $9,620 | $4,127 | 42.9% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 12 | 25 | $4,750 | $2,541 | 53.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $4,560 | $2,471 | 54.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $3,000 | $1,817 | 60.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $3,300 | $1,580 | 47.9% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 12 | 16 | $2,080 | $1,102 | 53.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 26 | 27 | $2,700 | $1,005 | 37.2% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 24 | 24 | $2,400 | $948.90 | 39.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 27 | 30 | $3,900 | $909.18 | 23.3% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 15 | 16 | $1,600 | $420.54 | 26.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 245 | 719 | $270,344 | $124,669 | 46.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 132 | 234 | $35,100 | $19,395 | 55.3% |
About Dr. Joseph Pean, MD
Dr. Joseph Pean, MD is a Pulmonary Disease healthcare provider based in Weslaco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1609873512.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Pean, MD has received a total of $1,176 in payments from pharmaceutical and medical device companies, with $366.99 received in 2024. These payments were reported across 16 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($1,163).
As a Medicare-enrolled provider, Pean has provided services to 2,608 Medicare beneficiaries, totaling 5,117 services with total Medicare billing of $626,758. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Weslaco, TX
- Active Since 07/07/2005
- Last Updated 10/02/2018
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609873512
Products in Payments
- Arikayce (Drug) $877.63
- ENDURANT IIS (Device) $108.12
- OPSUMIT (Drug) $98.29
- General - Thrombectomy (Device) $40.76
- TEZSPIRE (Biological) $19.35
- DIFICID (Drug) $18.91
- ZERBAXA (Drug) $12.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.